Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting

doi:10.1038/s41409-018-0161-1

Title: Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting

Full Record
Other Related Research

Publication Date:: 2018-04-13

Research Org.:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Org.:: USDOE Office of Science (SC)

OSTI Identifier:: 1498311

Resource Type:: Journal Article

Journal Name:: Bone Marrow Transplantation

Additional Journal Information:: Journal Volume: 53; Journal Issue: 10; Journal ID: ISSN 0268-3369

Country of Publication:: United States

Language:: ENGLISH

Citation Formats


                    Busca, Alessandro, Passera, Roberto, Maffini, Enrico, Festuccia, Moreno, Brunello, Lucia, Dellacasa, Chiara Maria, Aydin, Semra, Frairia, Chiara, Manetta, Sara, Butera, Sara, Iovino, Giorgia, Giaccone, Luisa, Sorror, Mohamed, Storb, Rainer, De Rosa, Francesco Giuseppe, and Bruno, Benedetto. Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting.  United States: N. p., 2018. 
        Web.  doi:10.1038/s41409-018-0161-1.

Copy to clipboard


                    Busca, Alessandro, Passera, Roberto, Maffini, Enrico, Festuccia, Moreno, Brunello, Lucia, Dellacasa, Chiara Maria, Aydin, Semra, Frairia, Chiara, Manetta, Sara, Butera, Sara, Iovino, Giorgia, Giaccone, Luisa, Sorror, Mohamed, Storb, Rainer, De Rosa, Francesco Giuseppe, & Bruno, Benedetto. Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting.  United States.  doi:10.1038/s41409-018-0161-1.

Copy to clipboard


                    Busca, Alessandro, Passera, Roberto, Maffini, Enrico, Festuccia, Moreno, Brunello, Lucia, Dellacasa, Chiara Maria, Aydin, Semra, Frairia, Chiara, Manetta, Sara, Butera, Sara, Iovino, Giorgia, Giaccone, Luisa, Sorror, Mohamed, Storb, Rainer, De Rosa, Francesco Giuseppe, and Bruno, Benedetto. Fri .  
        "Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting".  United States.  doi:10.1038/s41409-018-0161-1.

Copy to clipboard


                    
@article{osti_1498311,

  title        = {Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting},

  author       = {Busca, Alessandro and Passera, Roberto and Maffini, Enrico and Festuccia, Moreno and Brunello, Lucia and Dellacasa, Chiara Maria and Aydin, Semra and Frairia, Chiara and Manetta, Sara and Butera, Sara and Iovino, Giorgia and Giaccone, Luisa and Sorror, Mohamed and Storb, Rainer and De Rosa, Francesco Giuseppe and Bruno, Benedetto},

  abstractNote = {},

  doi          = {10.1038/s41409-018-0161-1},

  journal      = {Bone Marrow Transplantation},

  issn         = {0268-3369},

  number       = 10,

  volume       = 53,

  place        = {United States},

  year         = {2018},

  month        = {4}

}

Copy to clipboard

Journal Article:

DOI: 10.1038/s41409-018-0161-1

Other availability

Find in Google Scholar

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar records in OSTI.GOV collections:

Allogeneic hematopoietic cell transplantation after conditioning with I-131-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.

Journal Article Pagel, John M. ; Gooley, T. A. ; Rajendran, Joseph G. ; ... - Blood, 114(27):5444-5453

We conducted a study to estimate the maximum tolerated dose (MTD) of I-131-anti-CD45 antibody (Ab; BC8) that can be combined with a standard reduced-intensity conditioning regimen before allogeneic hematopoietic cell transplantation. Fifty-eight patients older than 50 years with advanced acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) were treated with (131)I-BC8 Ab and fludarabine plus 2 Gy total body irradiation. Eighty-six percent of patients had AML or MDS with greater than 5% marrow blasts at the time of transplantation. Treatment produced a complete remission in all patients, and all had 100% donor-derived CD3(+) and CD33(+) cells in the bloodmore »« less
DOI: 10.1182/blood-2009-03-213298
α-Imaging Confirmed Efficient Targeting of CD₄₅-Positive Cells After ²¹¹At-Radioimmunotherapy for Hematopoietic Cell Transplantation

Journal Article Frost, Sophia ; Miller, Brian W. ; Back, Tom ; ... - Journal of Nuclear Medicine

Alpha-radioimmunotherapy (α-RIT) targeting CD45 may substitute for total body irradiation in hematopoietic cell transplantation (HCT) preparative regimens for lymphoma. Our goal was to optimize the anti-CD45 monoclonal antibody (MAb; CA12.10C12) protein dose for astatine-²¹¹(²¹¹At)-RIT, extending the analysis to include intra-organ ²¹¹At activity distribution and α-imaging-based small-scale dosimetry, along with imunohistochemical staining. Methods: Eight normal dogs were injected with either 0.75 (n=5) or 1.00 mg/kg (n=3) of ²¹¹At-B10-CA12.10C12 (11.5–27.6 MBq/kg). Two were euthanized and necropsied 19–22 hours postinjection (p.i.), and six received autologous HCT three days after ²¹¹At-RIT, following lymph node and bone marrow biopsies at 2–4 and/or 19 hours p.i.more »« less
DOI: 10.2967/jnumed.115.162388
Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications

Journal Article Ballester, M. ; Obrador, D. ; Carrio, I. ; ... - Circulation; (USA)

The long-term clinical course and results of biopsies in 21 patients studied with monoclonal antimyosin antibodies more than 12 months after heart transplantation according to the presence and degree of antimyosin-antibody uptake is described. Eighteen men and three women aged 20-52 years (39 +/- 9 years) were studied with antimyosin antibodies 12-40 months (mean, 22 +/- 9 months) after heart transplantation, and followed for a mean of 18 months (10-28 months). The number of biopsies performed during follow-up was 102. Results showed normal antimyosin-antibody studies in nine patients and abnormal studies in 12 patients. Myocyte damage was identified in 18more »« less
DOI: 10.1161/01.CIR.82.6.2100
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation

Journal Article Aristei, Cynthia, E-mail: cynthia.aristei@unipg.it ; Carotti, Alessandra ; Palazzari, Elisa ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: We sought to determine whether the total body irradiation (TBI) schedule affected outcome in patients with acute leukemia in complete remission who received T cell–depleted allogeneic hematopoietic stem cell transplantation from HLA identical siblings. Methods and Materials: The study recruited 55 patients (median age, 48 years; age range, 20-66 years; 30 men and 25 women; 34 with acute myeloid leukemia and 21 with acute lymphoid leukemia). Hyperfractionated TBI (HTBI) (1.2 Gy thrice daily for 4 days [for a total dose of 14.4 Gy] from day −12 to day −9) was administered to 29 patients. Single-dose TBI (STBI) (8 Gy, at a median dose rate of 10.7 cGy/minmore »« less
DOI: 10.1016/J.IJROBP.2016.07.025
Immunosuppressive Total Lymphoid Irradiation-Based Reconditioning Regimens Enable Engraftment After Graft Rejection or Graft Failure in Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation

Journal Article Heinzelmann, Frank ; Lang, Peter J. ; Ottinger, Hellmut ; ... - International Journal of Radiation Oncology, Biology and Physics

Purpose: To retrospectively evaluate the efficacy of total lymphoid irradiation (TLI)-based reconditioning regimens in patients with graft failure or graft rejection after allogeneic hematopoietic stem cell transplantation. Methods and Materials: The results of 14 patients (7 adults and 7 children) with a variety of hematologic malignant diseases treated with a TLI-based reconditioning regimen with 7-Gy single-dose application plus anti-T-lymphocyte antibody OKT3 (n = 11) and/or antithymocyte globulin (n = 7)/fludarabine (n = 9), followed by an infusion of peripheral blood stem cells (n = 13) or bone marrow stem cells (n = 1) from related or unrelated donors, were retrospectivelymore »« less
DOI: 10.1016/j.ijrobp.2007.06.037

Similar Records